Fig. 3
From: Immunomodulatory effect of tibetan medicine compound extracts against ORFV in vitro by metabolomics
Differential metabolites analysis at 0 h. A Differential metabolites in 0-M1-O (1.9 μg/mL + ORFV group) and 0-CTRL (the control group) at 0 h. B Differential metabolites in 0-M2-O (3.8 μg/mL + ORFV group) and 0-CTRL (the control group) at 0 h. C Differential metabolites in 0-M3-O (7.6 μg/mL + ORFV group) and 0-CTRL (the control group) at 0 h. D Differential metabolites in 0-O (ORFV group) and 0-CTRL (the control group) at 0 h. E Venn diagram of differential metabolites in all groups at 0 h